| Product Code: ETC9944885 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Fragment Based Drug Discovery Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Fragment Based Drug Discovery Market - Industry Life Cycle |
3.4 United Kingdom (UK) Fragment Based Drug Discovery Market - Porter's Five Forces |
3.5 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Fragment Based Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the pharmaceutical industry in the UK |
4.2.2 Growing prevalence of chronic diseases driving the demand for innovative drug discovery solutions |
4.2.3 Technological advancements in fragment-based drug discovery techniques leading to more efficient drug development processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes for new drugs in the UK |
4.3.2 High costs associated with fragment-based drug discovery research and development |
4.3.3 Limited availability of skilled professionals in the field of fragment-based drug discovery in the UK |
5 United Kingdom (UK) Fragment Based Drug Discovery Market Trends |
6 United Kingdom (UK) Fragment Based Drug Discovery Market, By Types |
6.1 United Kingdom (UK) Fragment Based Drug Discovery Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Fragment Screening, 2021- 2031F |
6.1.4 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Biophysical Techniques, 2021- 2031F |
6.1.5 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By NMR Spectroscopy, 2021- 2031F |
6.1.6 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Differential Scanning Fluorimetry (DSF) Assay, 2021- 2031F |
6.1.7 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Fluorescence Polarization, 2021- 2031F |
6.1.8 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Isothermal Titration Calorimetry, 2021- 2031F |
6.1.9 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021- 2031F |
6.1.10 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021- 2031F |
6.2 United Kingdom (UK) Fragment Based Drug Discovery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.2.4 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.6 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.2.7 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Inflammation & Autoimmune Diseases, 2021- 2031F |
6.3 United Kingdom (UK) Fragment Based Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Academic & Research Institutions, 2021- 2031F |
6.3.3 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 United Kingdom (UK) Fragment Based Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
7 United Kingdom (UK) Fragment Based Drug Discovery Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Fragment Based Drug Discovery Market Export to Major Countries |
7.2 United Kingdom (UK) Fragment Based Drug Discovery Market Imports from Major Countries |
8 United Kingdom (UK) Fragment Based Drug Discovery Market Key Performance Indicators |
8.1 Number of research collaborations between pharmaceutical companies and academic institutions in the UK for fragment-based drug discovery projects |
8.2 Rate of adoption of new technologies and methodologies in fragment-based drug discovery by pharmaceutical companies in the UK |
8.3 Number of patents filed for novel drug candidates developed through fragment-based drug discovery in the UK |
9 United Kingdom (UK) Fragment Based Drug Discovery Market - Opportunity Assessment |
9.1 United Kingdom (UK) Fragment Based Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United Kingdom (UK) Fragment Based Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Fragment Based Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Fragment Based Drug Discovery Market - Competitive Landscape |
10.1 United Kingdom (UK) Fragment Based Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Fragment Based Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here